3 Results for "

sarbecovirus

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "sarbecovirus" in MCE Product Catalog:

6
6 Cited Publications
Cat. No.: HY-P99340
CAS No.: 2423014-07-5
Synonyms: VIR-7831 (WT IgG1); GSK-4182136 (WT IgG1)
Target:  

SARS-CoV

Research Areas:  

Infection Cancer

Sotrovimab (VIR-7831) (WT IgG1) is a human IgG1κ monoclonal antibody targeting the Sarbecovirus subgenus; it is capable of neutralizing SARS-CoV-2, SARS-CoV-1, and various other coronaviruses. Sotrovimab (WT IgG1) is a monoclonal antibody that retains the native, wild-type IgG1 Fc structure without any engineered modifications; unlike Sotrovimab (HY-P99340A), it does not contain the M428L or N434S mutations. Sotrovimab (WT IgG1) can be used for research on COVID-19 .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-152955
CAS No.: 2408723-12-4
Purity:  99.83%
Target:  

STING

Research Areas:  

Infection Inflammation/Immunology

STING agonist-22 (CF501) is a potent non-nucleotide STING agonist. STING agonist-22 is a adjuvant by activating STING to induce the type I interferon (IFN-I) response and proinflammatory cytokine production. STING agonist-22 can be used as an adjuvant to boost the original protein vaccine, producing potent, broad, and long-term immune protection. STING agonist-22 can be used for SARS-CoV-2 variants and sarbecovirus diseases research .
loading...
    loading...
Cat. No.: HY-173521
CAS No.: 3026520-19-1
Research Areas:  

Infection

JNJ-9676 is an orally active Coronavirus M protein inhibitor and selective Sarbecovirus inhibitor. JNJ-9676 binds to the M protein dimer and forces the protein into an alternative conformational state with a compound-induced binding pocket. JNJ-9676 demonstrates in vitro nanomolar antiviral activity against SARS-CoV-2, SARS-CoV and Sarbecovirus strains from bat and pangolin zoonotic origin .
loading...
    loading...